NCT06715995 · RECRUITING

Effects of Endogenous Gamma Light Stimulation on Brain Oscillations in Cognitively-normal Older Adults

This trial is testing whether a special table lamp that produces gamma-frequency light (without flickering) can change brainwave patterns and cognitive performance in healthy older adults. Researchers will measure EEG brain activity before and after lamp exposure, both immediately and over time. This is a Phase NA device study, meaning it is an early exploratory investigation rather than a large-scale efficacy trial.

You may qualify if

  • 1. Age over 55 years old.
  • 2. The Cognitive Abilities Screening Instrument (CASI) score is within normal ranges adjusted for age and education.
  • 3. Participants have no history of severe neurological or psychiatric disorders (such as stroke, epilepsy, depression, migraine, etc.) that could affect cognitive function.
  • 4. Participants have not used drugs that may affect cognitive function (e.g., benzodiazepines, anticholinergic medications, etc.).
  • 5. Participants with normal or corrected vision (e.g., glasses or contact lenses) to normal levels.
  • 6. Voluntary to sign the Informed Consent Form.

You're excluded if

  • 1. Participants enrolled in any cognitive enhancement study within the past two months.
  • 2. Participants with a history of disease that could affect cognitive function (e.g., cancer, autoimmune diseases, etc.).
  • 3. Pregnant, or planning to become pregnant.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2024-12-04

View full record on ClinicalTrials.gov

All APOE4 clinical trials